skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 21 - 40 of 63  for All Library Resources

previous page 1 Results 2 3 4 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
21
Diurnal Variation of Plasma Extracellular Vesicle Is Disrupted in People Living with HIV
Material Type:
Article
Add to My Research

Diurnal Variation of Plasma Extracellular Vesicle Is Disrupted in People Living with HIV

Pathogens (Basel), 2021-04, Vol.10 (5), p.518 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-0817 ;EISSN: 2076-0817 ;DOI: 10.3390/pathogens10050518 ;PMID: 33923310

Full text available

22
Pharmacological Inhibition of PPARy Boosts HIV Reactivation and Th17 Effector Functions, While Preventing Progeny Virion Release and de novo Infection
Material Type:
Article
Add to My Research

Pharmacological Inhibition of PPARy Boosts HIV Reactivation and Th17 Effector Functions, While Preventing Progeny Virion Release and de novo Infection

Pathogens & immunity, 2020-09, Vol.5 (1), p.177-239 [Peer Reviewed Journal]

Pathogens and Immunity 2020. ;Pathogens and Immunity 2020 2020 ;ISSN: 2469-2964 ;EISSN: 2469-2964 ;DOI: 10.20411/pai.v5i1.348 ;PMID: 33089034

Full text available

23
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Material Type:
Article
Add to My Research

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Nature (London), 2022-02, Vol.602 (7898), p.671-675 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Feb 24, 2022 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04389-z ;PMID: 35016199

Full text available

24
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
Material Type:
Article
Add to My Research

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Science Translational Medicine, 2020-09, Vol.12 (559) [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;ISSN: 1946-6234 ;EISSN: 1946-6242 ;DOI: 10.1126/scitranslmed.abc3103 ;PMID: 32817357

Digital Resources/Online E-Resources

25
Modeling the evolution of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2
Material Type:
Article
Add to My Research

Modeling the evolution of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2

PLoS computational biology, 2023-07 [Peer Reviewed Journal]

Attribution ;ISSN: 1553-734X ;EISSN: 1553-7358

Full text available

26
Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases
Material Type:
Article
Add to My Research

Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases

Annals of the rheumatic diseases, 2022-05, Vol.81 (5), p.720-728 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage ;Distributed under a Creative Commons Attribution 4.0 International License ;Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2021-221508 ;PMID: 35022159

Full text available

27
COVID-19 outbreak in vaccinated patients from a haemodialysis unit: antibody titres as a marker of protection from infection
Material Type:
Article
Add to My Research

COVID-19 outbreak in vaccinated patients from a haemodialysis unit: antibody titres as a marker of protection from infection

Nephrology, dialysis, transplantation, 2022-06, Vol.37 (7), p.1357-1365 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gfac016 ;PMID: 35104884

Full text available

28
Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells
Material Type:
Article
Add to My Research

Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells

Journal of virology, 2022-07, Vol.96 (14), p.e0060822-e0060822 [Peer Reviewed Journal]

Copyright © 2022 American Society for Microbiology. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2022 American Society for Microbiology. 2022 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/jvi.00608-22 ;PMID: 35862713

Full text available

29
Severe relapse of SARS‐CoV‐2 infection in a kidney transplant recipient with negative nasopharyngeal SARS‐CoV‐2 RT‐PCR after rituximab
Material Type:
Article
Add to My Research

Severe relapse of SARS‐CoV‐2 infection in a kidney transplant recipient with negative nasopharyngeal SARS‐CoV‐2 RT‐PCR after rituximab

American journal of transplantation, 2022-08, Vol.22 (8), p.2099-2103 [Peer Reviewed Journal]

2022 The American Society of Transplantation and the American Society of Transplant Surgeons. ;2022 The American Society of Transplantation and the American Society of Transplant Surgeons ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1600-6135 ;EISSN: 1600-6143 ;DOI: 10.1111/ajt.17000 ;PMID: 35150193

Full text available

30
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
Material Type:
Article
Add to My Research

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

Proceedings of the National Academy of Sciences - PNAS, 2022-05, Vol.119 (20), p.e2120976119-e2120976119 [Peer Reviewed Journal]

Copyright National Academy of Sciences May 17, 2022 ;Attribution ;Copyright © 2022 the Author(s). Published by PNAS. 2022 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2120976119 ;PMID: 35549549

Full text available

31
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
Material Type:
Article
Add to My Research

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma

Blood, 2022-02, Vol.139 (6), p.942-946 [Peer Reviewed Journal]

2022 American Society of Hematology ;Copyright ;Copyright © 2022 American Society of Hematology. All rights reserved. 2022 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2021013714 ;PMID: 34905598

Full text available

32
Th17 cell master transcription factor RORC2 regulates HIV-1 gene expression and viral outgrowth
Material Type:
Article
Add to My Research

Th17 cell master transcription factor RORC2 regulates HIV-1 gene expression and viral outgrowth

Proceedings of the National Academy of Sciences - PNAS, 2021-11, Vol.118 (48) [Peer Reviewed Journal]

Copyright © 2021 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Nov 30, 2021 ;Copyright © 2021 the Author(s). Published by PNAS. 2021 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2105927118 ;PMID: 34819367

Full text available

33
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
Material Type:
Article
Add to My Research

High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1

Journal of virology, 2024-01 [Peer Reviewed Journal]

Copyright ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/jvi.01351-23 ;PMID: 38088562

Digital Resources/Online E-Resources

34
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Material Type:
Article
Add to My Research

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

BioRxiv, 2021-02

2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.02.12.430472

Digital Resources/Online E-Resources

35
Virus isolation and neutralisation of SARS-CoV-2 variants BA.2.86 and EG.5.1
Material Type:
Article
Add to My Research

Virus isolation and neutralisation of SARS-CoV-2 variants BA.2.86 and EG.5.1

The Lancet infectious diseases, 2023-12, Vol.23 (12), p.e509-e510 [Peer Reviewed Journal]

2023. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(23)00682-5 ;PMID: 37949089

Full text available

36
Effect of metformin on the size of the HIV reservoir in non-diabetic ART-treated individuals: single-arm non-randomised Lilac pilot study protocol
Material Type:
Article
Add to My Research

Effect of metformin on the size of the HIV reservoir in non-diabetic ART-treated individuals: single-arm non-randomised Lilac pilot study protocol

BMJ open, 2019-04, Vol.9 (4), p.e028444-e028444 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2018-028444 ;PMID: 31005944

Full text available

37
COVID-19 outbreak in vaccinated patients from a hemodialysis unit: antibody titers as a marker of protection from infection
Material Type:
Article
Add to My Research

COVID-19 outbreak in vaccinated patients from a hemodialysis unit: antibody titers as a marker of protection from infection

Nephrology, dialysis, transplantation, 2022-02 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the ERA. ;The Author(s) 2022. Published by Oxford University Press on behalf of the ERA. 2022 ;ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gfac016 ;PMID: 35104884

Full text available

38
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection
Material Type:
Article
Add to My Research

Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection

The Journal of infectious diseases, 2021-11, Vol.224 (9), p.1489-1499 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. 2021 ;The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiab375 ;PMID: 34282461

Full text available

39
Neutralizing antibody levels as a correlate of protection against SARS‐CoV‐2 infection: a modeling analysis
Material Type:
Article
Add to My Research

Neutralizing antibody levels as a correlate of protection against SARS‐CoV‐2 infection: a modeling analysis

Clinical pharmacology and therapeutics, 2024-01 [Peer Reviewed Journal]

Attribution - NonCommercial ;ISSN: 0009-9236 ;EISSN: 1532-6535 ;DOI: 10.1002/cpt.3069 ;PMID: 37795693

Digital Resources/Online E-Resources

40
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
Material Type:
Article
Add to My Research

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies

NATURE COMMUNICATIONS, 2023-02, Vol.14 (1) [Peer Reviewed Journal]

ISSN: 2041-1723 ;EISSN: 2041-1723

Full text available

Results 21 - 40 of 63  for All Library Resources

previous page 1 Results 2 3 4 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (53)

Refine My Results

Creation Date 

From To
  1. Before 2015  (1)
  2. 2015 To 2016  (1)
  3. 2017 To 2018  (2)
  4. 2019 To 2020  (8)
  5. After 2020  (52)
  6. More options open sub menu

Resource Type 

  1. Articles  (61)
  2. Reports  (2)
  3. More options open sub menu

Searching Remote Databases, Please Wait